Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
While the two biopharmas remain partnered on multiple Tri-Specific Natural Killer cell Engager Therapies (TriNKET) candidates from collaborations dating back...